Ten Capital Wealth Advisors’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Ten Capital Wealth Advisors’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$254	–	436
2023 Q1	$254	Hold	1	–	–	﹤0.01%	530
2022 Q4	$104	Hold	1	–	–	﹤0.01%	574
2022 Q3	$0	Hold	1	–	–	﹤0.01%	612
2022 Q2	$0	Hold	1	–	–	﹤0.01%	512
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	456
2021 Q4	$2K	Buy	+1	New	+$6.1K	﹤0.01%	424

Other funds holding IRLA

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KAM

Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ten Capital Wealth Advisors's IRLA Position: Q2 2023 in Review

Ten Capital Wealth Advisors sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2023, closing a stake of 1 share — an estimated $254 sold.

Ten Capital Wealth Advisors first reported a position in IRLA in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q4 2021. 38 funds tracked by Wall St. Rank hold IRLA as of Q2 2023.

Ten Capital Wealth Advisors reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ten Capital Wealth Advisors sold 1 IRulya Therapeutics Inc. Common Stock share in Q2 2023, an estimated $254.
Ten Capital Wealth Advisors first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Ten Capital Wealth Advisors's IRulya Therapeutics Inc. Common Stock position peaked at $2K in Q4 2021.
38 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.